NO953878D0 - Umettede fosfonatderivater av puriner og pyrimidiner - Google Patents

Umettede fosfonatderivater av puriner og pyrimidiner

Info

Publication number
NO953878D0
NO953878D0 NO953878A NO953878A NO953878D0 NO 953878 D0 NO953878 D0 NO 953878D0 NO 953878 A NO953878 A NO 953878A NO 953878 A NO953878 A NO 953878A NO 953878 D0 NO953878 D0 NO 953878D0
Authority
NO
Norway
Prior art keywords
pyrimidines
purines
phosphonate derivatives
unsaturated phosphonate
antiviral agents
Prior art date
Application number
NO953878A
Other languages
English (en)
Other versions
NO953878L (no
Inventor
Patrick Casara
Jean-Francoise Nave
Serge Halazy
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NO953878D0 publication Critical patent/NO953878D0/no
Publication of NO953878L publication Critical patent/NO953878L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Saccharide Compounds (AREA)
NO953878A 1993-04-01 1995-09-29 Umettede fosfonatderivater av puriner og pyrimidiner NO953878L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93400842A EP0618214A1 (en) 1993-04-01 1993-04-01 Unsaturated phosphonate derivatives of purines and pyrimidines
PCT/US1994/001837 WO1994022882A1 (en) 1993-04-01 1994-02-25 Unsaturated phosphonates derivatives of purines and pyrimidines

Publications (2)

Publication Number Publication Date
NO953878D0 true NO953878D0 (no) 1995-09-29
NO953878L NO953878L (no) 1995-12-01

Family

ID=8214695

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953878A NO953878L (no) 1993-04-01 1995-09-29 Umettede fosfonatderivater av puriner og pyrimidiner

Country Status (17)

Country Link
EP (2) EP0618214A1 (no)
JP (1) JPH08508481A (no)
CN (2) CN1046288C (no)
AT (1) ATE154605T1 (no)
AU (1) AU681395B2 (no)
CA (1) CA2159451C (no)
DE (1) DE69403910T2 (no)
DK (1) DK0701562T3 (no)
ES (1) ES2105684T3 (no)
FI (1) FI113539B (no)
GR (1) GR3024788T3 (no)
HU (1) HUT72459A (no)
IL (1) IL109152A0 (no)
NO (1) NO953878L (no)
NZ (1) NZ263904A (no)
WO (1) WO1994022882A1 (no)
ZA (1) ZA942092B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
TW369536B (en) * 1996-01-18 1999-09-11 Mitsubishi Chem Corp Phosphonate nucleotide compounds
FR2781229B1 (fr) * 1998-07-17 2001-11-30 Univ Nice Sophia Antipolis Nouveaux composes analogues des nucleotides, leurs procedes de preparation et leurs applications
GB9821058D0 (en) 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
IL159494A0 (en) * 2001-06-29 2004-06-01 Acad Of Science Czech Republic 6-2'-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
JP2005508924A (ja) * 2001-08-30 2005-04-07 三菱ウェルファーマ株式会社 抗ウイルス剤
CA2527805C (en) 2003-06-16 2012-08-21 Institute Of Organic Chemistry And Biochemistry, Academy Of Sciences Of The Czech Republic Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
US20060252729A1 (en) 2003-07-30 2006-11-09 Krawczyk Steven H Nucleobase phosphonate analogs for antiviral treatment
JP5242375B2 (ja) * 2005-04-01 2013-07-24 ザ レゲントス オブ ザ ユニバーシティ オブ カリフォルニア ホスホノ−ペント−2−エン−1−イルヌクレオシド及び類似体
AU2006239677A1 (en) * 2005-04-25 2006-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
CN100352823C (zh) * 2005-08-19 2007-12-05 浙江车头制药有限公司 一种腺嘌呤衍生物的制备方法
US8324179B2 (en) 2007-02-09 2012-12-04 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
DK2794624T3 (da) 2011-12-22 2019-07-22 Geron Corp Guanin-analoger som telomerase-substrater og påvirkere af telomer-længde
JP6946353B2 (ja) 2016-02-18 2021-10-06 インバーサ, インコーポレイテッド 5′−アデノシン二リン酸リボース(adpr)の使用方法
ES2949441T3 (es) 2018-03-27 2023-09-28 Invirsa Inc Métodos para el uso de 5'-adenosina difosfato ribosa (ADPR)
CN108383872B (zh) * 2018-04-18 2019-07-12 南京师范大学 一种-1,1-二氟-3-磺酰基-2,4-戊二烯膦酸酯类化合物及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017054C (en) * 1990-05-16 1999-08-10 Jack S. Wilson Automatic storage and retrieval system
JPH05509307A (ja) * 1990-07-19 1993-12-22 ビーチャム・グループ・パブリック・リミテッド・カンパニー プリンの抗ウイルス性ホスホノ―アルケン誘導体
EP0531597A1 (en) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
CZ287745B6 (cs) * 1991-10-11 2001-01-17 Ústav organické chemie a biochemie AV ČR Acyklické fosfonomethoxyalkylsubstituované alkenylové a alkinylové deriváty purinu a pyrimidinu

Also Published As

Publication number Publication date
DE69403910T2 (de) 1998-01-29
HUT72459A (en) 1996-04-29
EP0701562A1 (en) 1996-03-20
DK0701562T3 (da) 1997-07-07
HU9502854D0 (en) 1995-11-28
EP0618214A1 (en) 1994-10-05
EP0701562B1 (en) 1997-06-18
CA2159451C (en) 1999-04-13
NZ263904A (en) 1996-11-26
AU681395B2 (en) 1997-08-28
JPH08508481A (ja) 1996-09-10
CN1120338A (zh) 1996-04-10
CA2159451A1 (en) 1994-10-13
FI113539B (fi) 2004-05-14
AU6516294A (en) 1994-10-24
ZA942092B (en) 1994-10-24
CN1229084A (zh) 1999-09-22
CN1046288C (zh) 1999-11-10
NO953878L (no) 1995-12-01
ATE154605T1 (de) 1997-07-15
IL109152A0 (en) 1994-06-24
FI954615A0 (fi) 1995-09-28
WO1994022882A1 (en) 1994-10-13
ES2105684T3 (es) 1997-10-16
FI954615A (fi) 1995-09-28
GR3024788T3 (en) 1998-01-30
DE69403910D1 (de) 1997-07-24

Similar Documents

Publication Publication Date Title
NO953878L (no) Umettede fosfonatderivater av puriner og pyrimidiner
PA8483101A1 (es) Compuestos quimicos
ES2148486T3 (es) Intermediarios de cloropirimidina.
NO912606D0 (no) Fremgangsmaate for fremstilling av 9-purinylfosfonsyrederivater.
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
ATE245646T1 (de) Therapeutische nukleoside
ES2175244T3 (es) Empleo de acido poliasparaginico y de sus sales.
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
ATE124412T1 (de) Antivirusderivate von (phosphonmethoxy)methoxy purin/pyrimidin.
IL98110A0 (en) N-(3-fluoro-2-phosphonylmethoxypropyl)derivatives of purine and pyrimidine heterocyclic bases,their preparation and use
FI924424A (fi) Hjaertskyddande tokoferolanaloger
DE68927651D1 (de) Derivate von Fluorphosphonat-Nukleotiden
DE69927251D1 (de) Verfahren zur herstellung von purinderivaten und dessen zwischenprodukte
DE68928752D1 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
ES2089159T3 (es) Nuevos derivados de acido ascorbico.
MX9306395A (es) Intermediarios novedosos para la preparacion de derivados 5,6-dihidropirrolo /2,3-d/-pirimidina y procesamiento para su obtencion.
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose